10.1080/09513590.2023.2181652 125 LinP
1 Introduction Ulcerative colitis (UC) is a chronic, relapsing form of inflammatory bowel disease (IBD) characterized by immune system dysfunction and pathological overactivation of mucosal immune responses, leading to persistent inflammation and subsequent colonic mucosal injury (Raine et al., 2022)
[3] In the phase 3a REDEFINE 2 trial in adults with overweight or obesity and type 2 diabetes, once-weekly cagrilintidesemaglutide (2.4 mg of each) produced an estimated mean body-weight change of 13.7% versus 3.4% for placebo over 68 weeks
What works optimally for one person may require adjustment for another
In some cases, this happens spontaneously, but more often it happens as a result of supportive dietary and lifestyle changes, nutritional therapies, medication, or surgery